These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. FDA is criticised for licensing high dose donepezil. Lenzer J BMJ; 2011 May; 342():d3270. PubMed ID: 21613347 [No Abstract] [Full Text] [Related]
6. How the FDA forgot the evidence: the case of donepezil 23 mg. Schwartz LM; Woloshin S BMJ; 2012 Mar; 344():e1086. PubMed ID: 22442352 [No Abstract] [Full Text] [Related]
7. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial. Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Ohbayashi T Dement Geriatr Cogn Disord; 2008; 25(5):399-407. PubMed ID: 18391486 [TBL] [Abstract][Full Text] [Related]
8. Extrapyramidal side-effect due to drug combination of risperidone and donepezil. Liu HC; Lin SK; Sung SM Psychiatry Clin Neurosci; 2002 Aug; 56(4):479. PubMed ID: 12109969 [No Abstract] [Full Text] [Related]
9. Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting. Wattmo C; Hansson O; Wallin AK; Londos E; Minthon L Dement Geriatr Cogn Disord; 2008; 26(3):203-11. PubMed ID: 18769065 [TBL] [Abstract][Full Text] [Related]
10. [Alzheimer dementia. Intervening as early as possible]. MMW Fortschr Med; 2002 Jan; 144(1-2):67. PubMed ID: 11847891 [No Abstract] [Full Text] [Related]
12. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan. Nozawa M; Ichimiya Y; Nozawa E; Utumi Y; Sugiyama H; Murayama N; Iseki E; Arai H Psychogeriatrics; 2009 Jun; 9(2):50-5. PubMed ID: 19604325 [TBL] [Abstract][Full Text] [Related]
13. [Advantages in long-term treatment with Cognex in Alzheimer disease]. Gracon S; Smith F; Shokry A Praxis (Bern 1994); 1997 Aug; 86(35):1350-4. PubMed ID: 9381027 [TBL] [Abstract][Full Text] [Related]
14. Donepezil and vitamin E for mild cognitive impairment. Ownby RL Curr Psychiatry Rep; 2006 Feb; 8(1):9. PubMed ID: 16513036 [No Abstract] [Full Text] [Related]
15. Preliminary communication: urodynamic assessment of donepezil hydrochloride in patients with Alzheimer's disease. Sakakibara R; Uchiyama T; Yoshiyama M; Yamanishi T; Hattori T Neurourol Urodyn; 2005; 24(3):273-5. PubMed ID: 15605367 [TBL] [Abstract][Full Text] [Related]
16. Medical treatment of Alzheimer's disease: past, present, and future. Ott BR Med Health R I; 2002 Jul; 85(7):210-2. PubMed ID: 12182092 [No Abstract] [Full Text] [Related]
17. Angle-closure glaucoma after discontinuing donepezil hydrochloride (Aricept). Enzenauer RW; Bowers PJ J Gerontol A Biol Sci Med Sci; 2005 Aug; 60(8):1083. PubMed ID: 16127117 [No Abstract] [Full Text] [Related]
18. Donepezil management of schizophrenia with associated dementia. Stryjer R; Bar F; Strous RD; Baruch Y; Rabey JM J Clin Psychopharmacol; 2002 Apr; 22(2):226-9. PubMed ID: 11910273 [No Abstract] [Full Text] [Related]
19. Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35). Tsunekawa H; Noda Y; Mouri A; Yoneda F; Nabeshima T Behav Brain Res; 2008 Jul; 190(2):224-32. PubMed ID: 18420288 [TBL] [Abstract][Full Text] [Related]
20. No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment. Auriacombe S; Pere JJ; Curr Med Res Opin; 2003; 19(8):715-7. PubMed ID: 14687442 [No Abstract] [Full Text] [Related] [Next] [New Search]